AI as a surgical Co-Pilot: predicting difficulty in rectal cancer

NCT ID NCT07761169

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether an AI tool called SurgDiff can predict how difficult rectal cancer surgery will be, based on MRI scans and patient data. The goal is to help surgeons choose the best surgical approach for each patient, potentially reducing complications. The study involves 68 adults with mid-low rectal cancer who are scheduled for surgery. Researchers will compare outcomes between patients whose surgical plan is guided by the AI and those who receive standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-assisted decision-making using the SurgDiff model, which predicts surgical difficulty from MRI scans and clinical data
What this could lead to
If successful, this could help surgeons choose the best surgical approach for rectal cancer, potentially reducing complications and improving outcomes.
What could go wrong
The trial is small (68 participants) and early, so the AI's predictions may not always be accurate or generalizable to all patients. There is also a risk that the model could misjudge difficulty, leading to suboptimal surgical choices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.